CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
6 hedge funds and large institutions have $416K invested in Cellular Biomedicine Group, Inc. in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$219K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$34K |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$152K |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$0 |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $219K | 17,025 | +17,025 | New |
|
|
2
Goldman Sachs
New York
| $152K | 11,798 | -8,252 | -41% |
|
|
3
UBS Group
Zurich,
Switzerland
| $34K | 2,663 | +2,663 | New |
|
|
BIT
4
BlackRock Institutional Trust
San Francisco,
California
| $10K | 800 | – | – |
|
|
MFS
5
MSI Financial Services
Springfield,
Massachusetts
| $1K | 100 | – | – |
|
6
Morgan Stanley
New York
| $0 | 33 | -3,131 | -99% |
|
|
7
Bank of America
Charlotte,
North Carolina
| – | – | -502 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | – | -170 | Closed |
|